Get the latest Science News and Discoveries

Weight Loss Drug Reduces Diabetes Risk by 94 Percent in Clinical Trial

Tirzepatide, the active ingredient in the popular weight loss drug Zepbound, has been shown to reduce the risk of developing type 2 diabetes in obese or overweight adults with pre-diabetes by a huge 94 percent.

None

Get the Android app

Or read this on Science Alert

Related news:

Snoring at Night? You Might Be at Risk for Uncontrolled Hypertension

Humanity’s newest brain gains are most at risk from ageing | The large prefrontal cortex provides evolutionary and cognitive advantages over non-human primates — but there’s a cost.

Does low lipoprotein(a) increase the risk of diabetes? New research suggests it does not - EurekAlert